HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytostatic murine B16 cell-pulsed dendritic cells induce effective protection against melanoma in mice.

AbstractBACKGROUND:
Peripheral blood mononuclear cells (PBMCs) present an antitumor activity in vitro on doxorubicin-resistant B16 melanoma (B16R) spheroids, but do not inhibit tumor growth in vivo. This study aimed to improve in vivo the antitumor immune response by using antigen presenting cells.
MATERIALS AND METHODS:
After injection of B16R cells, mice received either tumor cell lysate-pulsed PBMCs, or naive or cytostatic tumor cell-pulsed bone marrow-derived dendritic cells (DCs). Tumor development and mouse survival were followed and spleen cell cytotoxic activity against B16R was estimated in vitro by Lactate dehydrogenase activity measurement.
RESULTS:
The best results were obtained with peritumoral injections of cytostatic tumor cell-pulsed DCs which induced tumor regression, increased mouse survival and exhibited a higher splenocyte cytotoxic activity against B16R cells. When injected at a distant site, the efficacy was reduced. Furthermore, preventative injections of pulsed DCs induced protection of mice against B16R cells.
CONCLUSION:
These results show the important role of cytostatic tumor cell-pulsed DCs in a specific antitumor immunity establishment. Consequently, they could be used combined with other treatments to improve clinical outcomes.
AuthorsDebora Joseph-Pietras, Annie Carlier, Claudie Madoulet, Philippe Albert
JournalAnticancer research (Anticancer Res) 2007 Nov-Dec Vol. 27 Issue 6B Pg. 3865-74 ISSN: 0250-7005 [Print] Greece
PMID18225544 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Animals
  • Cell Growth Processes (immunology)
  • Dendritic Cells (immunology)
  • Female
  • Immunotherapy, Adoptive (methods)
  • Lymphocytes, Tumor-Infiltrating (immunology)
  • Melanoma, Experimental (immunology, pathology, prevention & control, therapy)
  • Mice
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: